Overview

A Study to Compare the Pharmacodynamics of Canagliflozin and Dapagliflozin in Healthy Volunteers

Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the pharmacodynamics (ie, how the drug affects the body) of canagliflozin with the pharmacodynamics of dapagliflozin.
Phase:
Phase 1
Details
Lead Sponsor:
Janssen-Cilag International NV
Treatments:
Canagliflozin
Dapagliflozin